GGrantIndex
← Leaderboards

California Pacific Med Ctr Res Institute

San Francisco, CA

Compare ↔
$319,438,596
Total funding
110
Grants

Funding over time

peak $38.3M · FY2005–25
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$318,983,772 · 109
CDC$454,824 · 1

By mechanism

R01$212,919,867 · 55
U19$47,969,588 · 8
U01$20,662,006 · 4
RF1$9,466,491 · 1
R56$5,873,786 · 4
R21$5,549,062 · 15

Investigators at California Pacific Med Ctr Res Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Russell T Hepple$14,589,5065 gr2Daniel Spencer Evans$911,2492 gr3Leon Lenchik$226,8881 gr

All-Time

Most funded here, all years

1Russell T Hepple$14,589,5065 gr2Luiz E Bermudez$7,151,7777 gr3Gregory J. Tranah$6,422,0399 gr4Robert J Debs$3,758,7763 gr5John L Muschler$1,861,5002 gr6Sean D McAllister$1,742,3362 gr7Robert G Miller$1,715,8631 gr8Garret L Yount$1,664,1473 gr

Largest grants

Study of Muscle, Mobility and Aging: SOMMA2$14,954,746
R01 · FY2025 · AG
Study of Muscle, Mobility and Aging: SOMMA2$12,573,238
R01 · FY2024 · AG
Prevention of Fractures in Patients with Parkinson's Disease$10,488,462
R01 · FY2020 · AG
Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL)$9,466,491
RF1 · FY2025 · AG
Longevity Consortium$8,845,192
U19 · FY2021 · AG
Prevention of Fractures in Patients with Parkinson's Disease$8,842,229
R01 · FY2018 · AG
Longevity Consortium$8,184,687
U19 · FY2018 · AG
Longevity Consortium$8,142,428
U19 · FY2020 · AG
Longevity Consortium$7,976,787
U19 · FY2019 · AG
Prevention of Fractures in Patients with Parkinson's Disease$6,941,547
R01 · FY2022 · AG
Longevity Consortium$6,913,922
U19 · FY2022 · AG
Study of Muscle, Mobility and Aging (SOMMA)$6,456,826
R01 · FY2018 · AG
Study of Muscle, Mobility and Aging (SOMMA)$5,818,929
R01 · FY2019 · AG
Proteomics of longevity$5,359,817
U19 · FY2022 · AG
Study of Muscle, Mobility and Aging (SOMMA)$5,132,942
R01 · FY2022 · AG
Study of Muscle, Mobility and Aging (SOMMA)$5,122,495
R01 · FY2021 · AG
Proteomics of longevity$4,553,906
U19 · FY2021 · AG
Proteomics of longevity$4,067,344
U19 · FY2020 · AG
Consortium to Study the Genetics of Longevity$4,055,000
U19 · FY2004 · AG
Study of Muscle, Mobility and Aging (SOMMA)$4,001,503
R01 · FY2020 · AG